Bestgate Wealth Advisors’s AbbVie ABBV Stock Holding History

Bestgate Wealth Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$455K	Hold	1,810	–	–	0.73%	28
2026 Q1	$394K	Hold	1,810	–	–	0.71%	28
2025 Q4	$414K	Hold	1,810	–	–	0.73%	29
2025 Q3	$419K	Buy	+1,810	New	+$369K	0.74%	30
2025 Q1	–	Sell	-1,810	Closed	-$322K	–	56
2024 Q4	$322K	Buy	+1,810	New	+$333K	0.65%	40

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Bestgate Wealth Advisors's ABBV Position: Q2 2026 in Review

Bestgate Wealth Advisors held its AbbVie (ABBV) position steady in Q2 2026 at 1,810 shares worth $455K. The position accounts for 0.73% of the portfolio, ranked #28.

Bestgate Wealth Advisors first reported a position in ABBV in Q4 2024 and has held it in 5 quarters since. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Bestgate Wealth Advisors held 1,810 shares of AbbVie worth $455K as of Q2 2026.
Bestgate Wealth Advisors left its AbbVie share count unchanged in Q2 2026.
AbbVie made up 0.73% of Bestgate Wealth Advisors's portfolio in Q2 2026, its #28 holding.
Bestgate Wealth Advisors first reported a position in AbbVie in Q4 2024 and has held it in 5 quarters since.
4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Bestgate Wealth Advisors's 13F filing for Q2 2026, filed 30 Jul 2026.